Clonal Hematopoiesis More Prevalent in Pediatric Cancer Survivors
Survivors of pediatric cancer have a higher rate of clonal hematopoiesis than their peers at any age, a study suggests.
Survivors of pediatric cancer have a higher rate of clonal hematopoiesis than their peers at any age, a study suggests.
The location of KIT mutations is associated with response to ripretinib and sunitinib in patients with previously treated GIST, research suggests.
Larotrectinib prolongs survival when compared with non-TRK inhibitor standard care in adults with TRK fusion-positive cancers, a study suggests.
Adding ganitumab to standard chemotherapy does not provide a benefit for patients with metastatic Ewing sarcoma, a phase 3 trial suggests.
The risk of early death in AYAs with cancer depends on the type of malignancy they have as well as multiple demographic factors, a study suggests.
The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS.
The incidence of Kaposi sarcoma is increasing among Black men and decreasing among White men in the United States, a study suggests.
None of the patients had grade 3 or higher acute radiation toxicity.
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
There are several factors that may increase the risk of thoracic soft tissue sarcoma in patients with a history of breast cancer.